Open house Arzneimittelrabattverträge zum Wirkstoff Filgotinib, ATC L04AF04

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse offers all interested pharmaceutical companies discount agreements with the above-mentioned active ingredient without any selection decision. The contracts are concluded as part of an “Open House model”. The offered contracts are not exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse. Under the Open House model, uniform conditions apply to all participants. Contract content, terms and conditions and access procedures are uniform—no individual negotiations are conducted. The contract terms are for a maximum of 24 months; the earliest possible contract start date is 01.11.2026. All contracts end no later than 24 months after the day of the earliest contract start date, regardless of the date on which the respective contract is concluded. Accession and/or contract conclusion within the 24-month period is possible, each time, on the first day of every month. There is a right of termination, each time 6 weeks before the end of the month, in accordance with the provisions of the contract. Further information on the possibilities for…

TENDER BRIEF

TENDER DOCUMENTS